Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 447.2K | $6.0M | 11.08% | -- | 2026-06-30 |
| Nantahala Capital Management, LLC | 400.0K | $5.0M | 9.91% | -- | 2026-06-30 |
| EcoR1 Capital, LLC | 400.0K | $5.0M | 9.91% | -- | 2026-06-30 |
| Siren, L.L.C. | 400.0K | $5.0M | 9.91% | -- | 2026-06-30 |
| Aberdeen Group plc | 400.0K | $5.0M | 9.91% | -- | 2026-06-30 |
| Samsara Biocapital, LLC | 400.0K | $5.0M | 9.91% | -- | 2026-06-30 |
| Vanguard Capital Management LLC | 78.7K | $1.0M | 1.95% | -- | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 10.6K | -- | 0.26% | -- | 2026-06-30 |
| Seven Grand Managers, LLC | 10.0K | -- | 0.25% | -- | 2026-06-30 |
| Morgan Stanley | 1.5K | -- | 0.04% | -- | 2026-06-30 |
